[A phosphorylated biguanide: benfosformin (JAV 852). I. Hypoglycemic and antidiabetic properties].
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology / Q000627:therapeutic use; D001645:Biguanides / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001786:Blood Glucose; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D006943:Hyperglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents; D007773:Lactates / Q000097:blood; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009943:Organophosphorus Compounds / Q000494:pharmacology / Q000627:therapeutic use; D010629:Phenformin / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D001593:Benzyl Compounds; D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007773:Lactates; D009943:Organophosphorus Compounds; C006690:benphosformine; D010629:Phenformin
Un biguanide phosphorylé: la benfosformine (JAV 852). I. Proprietés hypoglycémiantes et antidiabétiques.